For athletes in rugby, football, and hockey, the most immediate sign of a head injury is often a coach’s observation or a self-reported symptom, a process that can miss the subtle, cumulative impacts linked to long-term brain health. A new London-based startup, CTEye, is betting that the answer lies not in subjective assessment, but in data collected from inside the mouth. The company, incorporated in late 2025, has secured pre-seed funding to develop a smart mouthguard designed to monitor brain health in real time during contact sports [UK Business Angels Association, April 2026]. The investment, led by the Royal College of Art's Design & Innovation Fund with participation from Infinity Asset Management LLP, signals an early vote of confidence in a hardware approach to a persistent clinical problem.
The Design-Led Hardware Wedge
CTEye’s core thesis is that a mouthguard, a piece of protective equipment already mandated in many sports, is the ideal form factor for an impact sensor. It sits securely against the upper jaw, providing a stable platform to measure linear and rotational forces transmitted through the skull. While the company has not yet released detailed product specifications or clinical validation data, its backing from a premier design institution is a notable differentiator. The Royal College of Art's fund specifically targets early-stage companies founded by its graduates and staff, suggesting CTEye’s founding team likely has a strong industrial design and human-centered engineering background [Startups Magazine, Retrieved 2026]. This design focus could be critical for user adoption, as the device must be comfortable, durable, and unobtrusive enough for athletes to wear consistently during play.
The path to market, however, is not merely about hardware elegance. For any device making claims about brain health monitoring, regulatory clearance is a non-negotiable hurdle. CTEye’s product would likely need to navigate classifications with bodies like the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) or the U.S. Food and Drug Administration (FDA), a process that demands robust clinical evidence. The company’s stated goal of combating neurodegenerative disease points to ambitions beyond simple impact detection, potentially aiming for a device that can track biomarkers or provide actionable data for long-term health management.
A Crowded Field of Competitors
The market for instrumented mouthguards is already active, with several companies having a multi-year head start. This creates a significant competitive pressure for CTEye, which must carve out a niche in a field populated by both established sports brands and specialized healthtech firms.
| Competitor | Notable Product / Focus |
|---|---|
| Prevent Biometrics | The Impact Monitoring Mouthguard, used in NCAA and professional sports. |
| HitIQ | Focus on analytics and data platform for rugby and other sports. |
| ORB Innovations | The ORB Smartguard, another sensor-equipped mouthguard. |
| OPRO | A major custom mouthguard brand with potential to integrate sensing. |
CTEye’s most plausible answer to this field is its design-led origin and its specific backing from an innovation fund focused on medtech and advanced materials. Success will depend on its ability to not just match existing sensor accuracy, but to improve upon form factor, data insights, or integration into broader athlete health ecosystems in a way that resonates with teams, leagues, and individual athletes.
The disease state in focus here is chronic traumatic encephalopathy (CTE) and other traumatic brain injuries, primarily affecting athletes in high-impact sports like American football, rugby, ice hockey, and boxing. For these athletes, the current standard of care is reactive and observational. Diagnosis typically follows a reported or witnessed concussion event, relying on sideline assessment tools like the SCAT5 (Sport Concussion Assessment Tool), which evaluates symptoms, cognition, and balance. There is no widely adopted, objective, in-game physiological monitor that can track sub-concussive hits,the repeated, lower-force impacts believed to contribute significantly to long-term neurodegeneration. The smart mouthguard category aims to fill this diagnostic gap, providing a continuous stream of objective data that could inform immediate removal-from-play decisions and contribute to a longitudinal health record.
Sources
- [UK Business Angels Association, April 2026] CTEye secures pre-seed funding from the Royal College of Art’s Design & Innovation Fund to combat neurodegenerative disease with smart mouthguard technology | https://ukbaa.org.uk/blog/2026/04/15/cteye-secures-pre-seed-funding-from-the-royal-college-of-arts-design-innovation-fund-to-combat-neurodegenerative-disease-with-smart-mouthguard-technology/
- [Startups Magazine, Retrieved 2026] Information on the Royal College of Art's Design & Innovation S/EIS Investment Fund I | https://www.startupsmagazine.co.uk/article-royal-college-art-launches-angel-fund-its-entrepreneurial-alumni-and-staff